GL1X · GenesisL1 explorer

Research workbench

Crystal structure of TNKS2 in complex with (5S)-5-methyl-5-[4-(4-oxo- 3,4-dihydroquinazolin-2-YL)PHENYL]IMIDAZOLIDINE-2,4-dione

Analyse Crystal structure of TNKS2 in complex with (5S)-5-methyl-5-[4-(4-oxo… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5OWT
Type
protein
Length
411 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tankyrase-2
EC
2.4.2.30
UniProt
Q9H2K2
Ligands
F37, ZN, SO4
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 24% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATankyrase-2 (EC 2.4.2.30)protein20324% helix, 30% strandQ9H2K2
BTankyrase-2 (EC 2.4.2.30)protein20824% helix, 30% strandQ9H2K2

Ligands and binding sites

  • F37 · (5S)-5-methyl-5-[4-(4-oxidanylidene-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14560.800.8766SO4, F37
22290.660.8340SO4, F37
3900.460.8020empty
4510.370.8016empty

Interfaces

1 interface between chains.

  • A–B · 628 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5OWT · Crystal structure of TNKS2 in complex with (5S)-5-methyl-5-[4-(4-oxo-3,4-dihydroquinazolin… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.